Laboratorios Farmaceuticos ROVI

Laboratorios Farmaceuticos ROVI Market capitalization

The The market capitalization of Laboratorios Farmaceuticos ROVI (ROVI.MC) as of Nov 15, 2026 is 3.89 B EUR. In the previous year, The market capitalization was 3.89 B EUR — a change of 0.00% (lower).

Market capitalization

3.89 BEUR

YoY

0.00%

Last updated:

In 2025, Laboratorios Farmaceuticos ROVI's market cap stood at 3.89 B EUR, a 0.00% increase from the 3.89 B EUR market cap in the previous year.

The Laboratorios Farmaceuticos ROVI Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2018
3.89 B EUR
Jan 1, 2019
3.89 B EUR
Jan 1, 2020
3.89 B EUR
Jan 1, 2021
3.89 B EUR
Jan 1, 2022
3.89 B EUR
Jan 1, 2023
3.89 B EUR
Jan 1, 2024
3.89 B EUR
Jan 1, 2025
3.89 B EUR
The Laboratorios Farmaceuticos ROVI Market capitalization history
YEARMarket capitalizationYoY
3.89 BEUR0.00%
3.89 BEUR0.00%
3.89 BEUR0.00%
3.89 BEUR0.00%
3.89 BEUR0.00%
3.89 BEUR0.00%
3.89 BEUR0.00%
3.89 BEUR0.00%
3.89 BEUR0.00%
3.89 BEUR0.00%
3.89 BEUR0.00%
3.89 BEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Laboratorios Farmaceuticos ROVI Stock analysis

What does Laboratorios Farmaceuticos ROVI do? Laboratorios Farmaceuticos ROVI SA is a Spanish pharmaceutical company that was founded in 1946 by Salvador and Ignacio Ruiz-Salmones. The company is headquartered in Madrid and employs over 1,000 employees. ROVI manufactures a variety of pharmaceutical products and offers services in various areas. The company specializes in the development and manufacturing of specialty preparations in the fields of oncology, hematology, endocrinology, and gastroenterology. The company operates in three business areas: specialty pharmaceuticals, contrast agents, and active ingredients for the industry. The specialty pharmaceuticals business area includes medications for various applications, such as the treatment of cancer, blood disorders, endocrine disorders, gastroenterological disorders, and central nervous system disorders. The contrast agents division produces products for radiology and diagnostics. The products are used in various medical fields, from cardiology to gastroenterology. In the active ingredients for the industry business area, ROVI manufactures active ingredients for other pharmaceutical companies. ROVI specializes in the production of specialty products and relies on collaborations with other companies. The company has strategic partnerships with many companies such as GlaxoSmithKline, Pfizer, Sanofi-Aventis, and Zeltia. This also includes some research collaborations to develop and market products together. The company is also dedicated to the development of biosimilars, which allow for the offering of biologic drugs at a lower price. Biosimilars are copies of biopharmaceuticals that are usually very expensive due to the complex manufacturing process and high development costs. ROVI is also a major producer of vaccines that are distributed worldwide. ROVI has followed a solid growth trajectory in recent years. The company has been able to consistently increase its revenue and profit and is now a major player in the pharmaceutical industry. The company also operates a strong research and development department that constantly develops new products and technologies to improve patient care. In summary, Laboratorios Farmaceuticos ROVI SA is a leading pharmaceutical company specializing in the manufacturing of specialty products. With its subsidiaries in Europe and the USA, ROVI has an international presence and has made a name for itself through its expertise in the development and manufacturing of innovative pharmaceutical products. Laboratorios Farmaceuticos ROVI is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Laboratorios Farmaceuticos ROVI's Market Capitalization

Laboratorios Farmaceuticos ROVI's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Laboratorios Farmaceuticos ROVI's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Laboratorios Farmaceuticos ROVI's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Laboratorios Farmaceuticos ROVI’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Laboratorios Farmaceuticos ROVI stock

The market capitalization of Laboratorios Farmaceuticos ROVI is 3.89 B EUR in 2025.

The market capitalization of Laboratorios Farmaceuticos ROVI changed from 3.89 B EUR to 3.89 B EUR, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Laboratorios Farmaceuticos ROVI since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's EUR, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' EUR varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Laboratorios Farmaceuticos ROVI with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Laboratorios Farmaceuticos ROVI

All Key Metrics — Laboratorios Farmaceuticos ROVI